Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.Bone Marrow Transplant.(2018).
Revised-International Staging System (R-ISS) is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM)..Biol Blood Marrow Transplant.(2018).
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.Cancer.(2016).
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.Am J Hematol.(2016).
Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.Biol Blood Marrow Transplant.(2016).
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the ASBMT.Biol Blood Marrow Transplant.(2015).
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials.Front Med (Lausanne)2, 89.(2015).
Umbilical cord blood: advances and opportunities.Cytotherapy17, 693-694.(2015).